Ping‐Yi Wu

400 total citations
9 papers, 193 citations indexed

About

Ping‐Yi Wu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ping‐Yi Wu has authored 9 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Ping‐Yi Wu's work include Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers) and RNA Interference and Gene Delivery (3 papers). Ping‐Yi Wu is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers) and RNA Interference and Gene Delivery (3 papers). Ping‐Yi Wu collaborates with scholars based in Taiwan, United States and United Kingdom. Ping‐Yi Wu's co-authors include Mi‐Hua Tao, Koichi Tsuneyama, Chia‐Ming Chang, Yi‐Ting Tsai, Ching‐Cheng Chang, I‐Jung Lee, Long‐Sheng Lu, Shuk‐Man Ka, Patrick S.C. Leung and Amy Dhirapong and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and International Journal of Cancer.

In The Last Decade

Ping‐Yi Wu

9 papers receiving 190 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping‐Yi Wu Taiwan 7 109 72 60 36 34 9 193
Jessica Voss United States 6 190 1.7× 67 0.9× 46 0.8× 19 0.5× 32 0.9× 9 281
Jiesheng Li China 6 97 0.9× 67 0.9× 68 1.1× 19 0.5× 54 1.6× 9 218
Evelyn Roth Germany 6 288 2.6× 79 1.1× 34 0.6× 22 0.6× 72 2.1× 7 338
Lu‐En Wai Singapore 6 111 1.0× 75 1.0× 37 0.6× 18 0.5× 34 1.0× 13 190
Nelly Bonilla France 10 232 2.1× 61 0.8× 55 0.9× 15 0.4× 30 0.9× 15 317
Natalie J. Neubert Switzerland 5 151 1.4× 114 1.6× 56 0.9× 13 0.4× 15 0.4× 6 224
Valérie Janelle Canada 11 206 1.9× 148 2.1× 73 1.2× 57 1.6× 25 0.7× 15 299
Davide Botta United States 7 224 2.1× 55 0.8× 37 0.6× 32 0.9× 24 0.7× 13 309
Thordis Hohnstein Germany 4 173 1.6× 63 0.9× 54 0.9× 16 0.4× 21 0.6× 5 252
Nadia Mensali Norway 9 150 1.4× 112 1.6× 65 1.1× 13 0.4× 26 0.8× 16 252

Countries citing papers authored by Ping‐Yi Wu

Since Specialization
Citations

This map shows the geographic impact of Ping‐Yi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Yi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Yi Wu more than expected).

Fields of papers citing papers by Ping‐Yi Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping‐Yi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Yi Wu. The network helps show where Ping‐Yi Wu may publish in the future.

Co-authorship network of co-authors of Ping‐Yi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Ping‐Yi Wu. A scholar is included among the top collaborators of Ping‐Yi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping‐Yi Wu. Ping‐Yi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Cheng, Ya‐Wen, Tai‐Ling Chao, Shenghan Wang, et al.. (2020). Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects. SSRN Electronic Journal. 3 indexed citations
2.
Tsai, Yi‐Ting, I‐Jung Lee, Ping‐Yi Wu, et al.. (2018). Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment. OncoImmunology. 7(9). e1477459–e1477459. 49 indexed citations
3.
Lee, I‐Jung, et al.. (2017). Radiation improved IL-21 cancer immunotherapy. The Journal of Immunology. 198(Supplement_1). 204.21–204.21. 1 indexed citations
4.
Sun, Cheng‐Pu, Hui-Hsien Chou, Tzu‐Hui Wu, et al.. (2015). Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice. Scientific Reports. 5(1). 15259–15259. 18 indexed citations
5.
Sun, Cheng‐Pu, Tzu‐Hui Wu, Chun‐Chi Chen, et al.. (2013). Studies of Efficacy and Liver Toxicity Related to Adeno-Associated Virus–Mediated RNA Interference. Human Gene Therapy. 24(8). 739–750. 16 indexed citations
6.
Chang, Chia‐Ming, Yin Chen, Ping‐Yi Wu, et al.. (2010). Treatment of Hepatocellular Carcinoma with Adeno-Associated Virus Encoding Interleukin-15 Superagonist. Human Gene Therapy. 21(5). 611–621. 35 indexed citations
7.
Chang, Chia‐Ming, Yin Chen, Ping‐Yi Wu, et al.. (2010). Differential antitumor effect of interleukin‐12 family cytokines on orthotopic hepatocellular carcinoma. The Journal of Gene Medicine. 12(5). 423–434. 28 indexed citations
8.
Leung, Patrick S.C., Amy Dhirapong, Ping‐Yi Wu, & Mi‐Hua Tao. (2009). Gene therapy in autoimmune diseases: Challenges and opportunities. Autoimmunity Reviews. 9(3). 170–174. 20 indexed citations
9.
Huang, Hsing‐I, et al.. (2003). Improved immunogenicity of a self tumor antigen by covalent linkage to CD40 ligand. International Journal of Cancer. 108(5). 696–703. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026